Neurotech International (ASX:NTI) has appointed Bonni Goldstein as Chief Medical Advisor in the US, according to a Monday Australian bourse filing.
Goldstein is a physician with more than 25 years of clinical experience, including 17 years focused on cannabinoid-based therapeutics.